Human Clinical Trails To Bears With Omni Bio

Omni Bio Pharmaceutical Inc. a clinical-stage biopharmaceutical company, declared the idea of commencing new human clinical trails to test the ability of Alpha-1 antitrypsin (AAT) for the medication of Type 1 diabetes and Graft Versus Host Disease (GVHD).

Experiment at Omni Bio aimed at placebo-controlled Type 1 diabetes in anticipating clinical trial to analyze on young subjects. The company intends the principle human clinical trail as the treatment of lethal impediment of bone marrow transplantation, which is also called as GVHD. To fund these trails the company will have to arrange funds but it is not guaranteed that it will be successful in case to raise investments.

Barbara Davis Center for Childhood Diabetes concluded with a new Type 1 diabetes trail that builds on initial research from latest full proof of principle Type 1 diabetes was successful, said Dr. James Crapo, Omni Bio’s Chief Executive Officer.

Preventing of GVHD has associated with the treatment of Type 1 diabetes as both are safe disease. AAT treatment GVHD assured in animal models.

Zioptan, FDA Approved Treatment for Glaucoma

WHITHOUSE STATION – Merck commonly called a MSD in United States told that Food and Drug Administration has given green signal to ZIOPTAN(TM). ZIOPATAN is used in to deduce the effects of elevated intraocular pressure (IOP) in patients with Ocular hypertension. The FDA approved the medication after there was a two year clinical research of almost 905 subjects. The clinical research it was found that ZIOPTAN has IOP lowering effect. Merck has told that ZIOPTAN will be sold to customers till March.

Information about the ZIOPTAN
ZIOPTAN makes alterations in pigmented tissues. The pigmentation has increased in iris pigmentation, periorbital tissue, and eye lashes. The ZIOPTAN should be used with caution with aphakic patients as high risk is involved in it. The further study needs to be done whether pregnant women should be allowed to take ZIOPTAN. The fetus may in any way be in danger due to the use of ZIOPTAN the researchers are dealing with that issue. The pediatric patients are barred to use ZIOPTAN as there is long term implication associated with that kind of patients.

Recommended Usage of ZIOPTAN
The recommended dosage is one drop of ZIOPTAN in conjunctival sac of eye of patients daily in the evening.

Agreement among Merck and Santen It was on 15, April, 2009 that both the pharmacy company collaborated together for Tafluprost. Merck has commercial rights in North America, South Africa, Western Europe, Middle East, Australia and many more area around the world. The Santen handles the market in places like Germany, countries of Asia Pacific, Northern Europe and many more.

Information regarding Merck and Santen
The Merck is a huge world wide healthcare company. The Merck works with more than 140 countries to give them health solutions. The Santen Is a pharmacy company which has its base in Osaka and works in fields ophthalmic, eyesight, and health.

FDA Approves Once a Week Type 2 Diabetes Drug

An application was filed for approval for its weekly diabetes medicine named as Bydureon, a product of Amylin Pharmaceuticals.

Finally FDA has approved the drug. Bydureon is type 2 Diabetes drug to be taken once a week.

Unlike other diabetes drugs such as generic Actos, generic Amaryl and generic Avandia, Bydureon is in injection diabetes medicine. A manufacturing division located at 8814 Trade Port Drive will be producing these injections.

Amylin announced about the approval given on 27th January by FDA. Company has planned to launch the drug in February 2012. Diabetes patients can expect to see the drug in pharmacies in mid February 2012.

Bydureon (exenatide) is receptor agonist for glucagon-like peptide-1 (GLP-1) which improves glycemic control in type 2 diabetes patients. Efficacy of Bydureon is said to be best when administered with proper diet and exercise. Diabetes Medicines

Amylin first launched its manufacturing plant in 2009 and for Bydureon it received, along with other companies such as Lilly and Alkemes, response letter from FDA on April 23 2010. By the time US FDA approves the drug, Amylin launched the drug in Europe Commission which got approval in 2011. Bydureon is also in approval queue in Asian countries like Japan.

Industry experts are happy that finally long acting diabetes drug will be available to millions of diabetes patients in USA. Eyes are on how the drug is going to perform in market.

Amylin is however is not planning to hire more staff because of approval as current staff unit is already manufacturing Bydureon for European market. As USA approval was soon expected, company employees already had increased production.

According to company current numbers of employees are ample to meet demand and it is prepared to hire new people if demand increases.

Embryos Growth Could Pedict Risk In Pregnancy

Scientists have found link between miscarriages and overall growth of embryo in the 12-14 weeks of pregnancy, which leads two ways to have treat such tragedies.

A study found around 80 percent of embryos pregnant women who concluded with miscarriages involved fetus with restricted growth in the session of 3 moths.

This study will predict those mothers at risks.

Dr. Shyamaly Sur stated as in Daily Express that restrict growth in embryos in early stage of pregnancy would relate to subsequent miscarriage.

This system will ensure those pregnancies at risk of miscarriage . The team measured the length, more then 500 single and twin embryos conceived through IVF during the first 12 week of pregnancy, a study revealed .
In Vitro Fertilisation ( IVF ) mothers could determine the exact gestational age. The baby’s full length from top to bottom was recorded from ultrasound scan.

Researchers found that 78 percent of single embryos pregnancies which miscarried were growth restricted, where as 98 percent of those haven’t miscarry were not growth stunted. Only 29 percent of poor growth leads to miscarriages.

Abnormality of the fetus or something in the environment of womb could be the reason as to why embryos show restricted growth in early stage of pregnancy. A study is going on to investigate miscarriages more in detail.

Sanofi and Selecta to Develop Food Allergy Treatment

Selecta, a USA- Massachusetts, based company has announced to develop immunotherapies for treating life-threatening allergies caused by food. SVP (synthetic vaccine particle) platform will be used to identify and develop a compound.

Nanoparticles will be developed with the help SVP technology, an immunotherapy platform developed by Selecta. These particles would help in balancing over response to specific antigens and thereby producing immune tolerance.

The license of the compound to be used in immunotherapy will be possessed by Sanofi, a french pharmaceutical giant. Also, Sanofi will have an option for two additional compounds for treating food allergies caused by specific aeroallergens or food. Atarax

Selecta, in return, will get an estimated $300m for one allergen indication of total three immunotherapy compounds.

Sanofi is pharmaceutical giant in immunology and vaccines. Selecta is happy by collaboration with Sanofi to develop commercial pharmaceutical products using its SVP technology.

A safe treatment with higher efficacy which targets specific antigen is needed to stop inappropriate immune reactions by body immune system. The treatment would be useful in development of other treatments for which immune response is problem such as lysosomal storage disease.

The SVP technology restores balance in body immune systems. It does that by developing tolerance in immune systems for specific antigens.

Although the focus of the co-operation is different from other co-operations between pharmaceutical companies and technology firm, the structure of the pact is somewhat similar i.e. to allows firm to access library of the compounds. This is the third such pact. Pacts between GSK and Chiromics, Novartis and MorphoSys are examples.

Fast Pain Reliever Method Under Trial

Before any surgery patients are given anesthesia to numb the portion of the body. That is to reduce the pain while performing operation. But for treatments, such as root canal of teeth, cosmetic surgeries, short acting anesthesia is used on patient. Short term anesthesia has couple of shortcomings such as effect last for few hours, impaired eye sight and unable to eat or talk.

A new development has been made by experts to subdue problems caused by short acting anesthetic. Scientists have developed a new molecule which can be used as fast acting pain relievers. The molecule, as demonstrated at Nature, works by getting activated when shed a beam of light on it. Activated molecule silences pain causing neurons. The molecule is then deactivated by light to terminate its effect. This new instant pain reliever is believed to be significant progress and likely to be most favorite pain reliever in general clinics.

General anesthetics bring numbness by blocking electrical signals generated by ending of nerve cells. The endings of nerve cells are medically known as Nociceptors. Nociceptors generate signals when cold, heat or mechanical pressure exceeds threshold limit. These generated signals are due to reach central nervous system which, after following numerous chain reactions, eventually results in feeling of pain.

Most commonly used anesthetic is Xylocaine. It works by blocking nociceptors from generating signals of pain. There are many other local anaesthetics also and all of them work in somewhat similar way. Problem with these current anesthetics is regardless of specific nociceptors they act on all the neurons. The new molecule based pain reliever method is selective in nature. With that being said, the method acts only on desired area of the body.

The development of new molecule known as Ammonium-azobenzene-quaternary ammonium is a result of combined efforts by scientists of California Uni and Ludwig-Maximilians Munich. Dr Richard Kramerof California and Dr Dirk Trauner are lead researcher of their respective group. The molecule changes its shape when exposed to green light and returns to its original shape when exposed to ultraviolet beam of light. The change in shape occurs within hundreds of part of a millisecond. This makes the molecule super fast acting pain reliever.
The trial of the new method has been successful.

Sleep Apnea Treatment Helps Diabetes and Blood Pressure

A study has been carried out to check effect of sleep apnea treatment on blood pressure and diabetes. The study was done only on men. Experts found that blood pressure lowered in men who were treated with positive airway pressure. Study result is available online at Journal of Clinical Sleep Medicine

All kinds of blood pressure patients are expected to be benefited including patients of chronic diseases, according to Dr Bharati Prasad - head of research study. A prospective study on sleep apnea patients with other chronic diseases should be done.

The study was participated by 221 men who were diagnosed with obstructive sleep apnea and also having type-II diabetes or high blood pressure. All the patients were treated with CPAP therapy i.e. positive airway pressure.

Systolic and diastolic blood pressure numbers were reduced at the beginning of the PAP therapy, and between 3 to 6 months afterward, and during the second follow-up period between 9 to 12 months later.

Systolic and diastolic pressure were reported lower after starting PAP therapy. The level further reduced after 3-6 months of the therapy and after 9-12 months.

Mapping of Breast Cancer May Lead to New Treatment

Scientists have claimed to finish mapping of genetic mutations in breast cancer. Genetic mutation is an important process in Cancer. Mapping of such process would give better understanding to develop more effective treatment. This study is likely going to change the current course of treatment.

The study has revealed some startling facts. One such finding is that genetic of one of the deadliest types of breast cancer is nearer to ovarian cancer than other breast cancer. Findings of the study have been published on Journal Nature.

The discovery is expected to benefit breast cancer patients very soon, said Dr Matthew Ellis. Dr Ellis, a co-leader of the study, is from Washington University School of Medicine. Triple negative breast cancer treatment would be better with less toxic chemotherapy.

The study also indicates sea-change in how differently cancer is being seen. Now it’s not just where tumor originated but understanding cancer cells at molecular level.

The study is the part of research project called Cancer Genome Atlas. The project is supervised by Dr Brad Ozenberger at National Institutes of Health. The project would provide drug companies a clear direction on which genetic mutation should be the target of their new drug.

There can be lot of information drug companies can use to design their treatment. For example, scientists may find a gene involved in immune system which ultimately help them understand as how cancer escapes body's immune system. Genome atlas has also revealed that drugs that block growth of new blood vessel can be useful against triple-negative breast cancer and ovarian cancer.

Prostate Health Diet for Complete Wellness

A proper diet is what is very important to lead a healthy living. Especially for men, prostate health should be taken care of. The glands are very sensitive and should be specially taken care of with providing proper nutrition through incorporating healthy diets and routine.

The basic ingredients required for a complete prostate health is adequate consumption of Beta-sitosterol, it is the core element that is available in natural herbs like saw palmetto and pygeum. It has got the abilities to boost prostate health through providing complete nutrition that makes it healthier. The quality component is also present in sugar cane pulp, which serves as the best solution that reduces the causes of prostate enlargement.
Natural elements work best
Fish oil or flax seeds, it is the best nutritional element that helps to nurture overall health. These oils contain omega 3 and omega 6 nutrients helping to maintain prostate health to the core. Even, olive oil and vegetable oils are also loaded with omega 3 nutrients, which protect the cells with anti-inflammatory properties. Soy food, have also been showing positive effects on overall prostate health as these elements contain the effective elements of photo estrogen. Even ionic minerals serve as the great nutritional benefit for foods serving powerful for ranging complete prostate health which also can affect one’s sexual health such as erectile dysfunction drugs in men and sexual dysfunction in women.

Best Diabetic Diets, Blood Sugar Control Diet

It is a condition in which the blood sugar becomes abnormally high. A proper diet, however, can effectively control this condition. A Diabetes control meal, along with prescribed medicines, is the key to manage fluctuation in sugar levels. Patients will face difficulty managing their this health disorder if certain foods are consumed. The main aim of meal is to control the glucose without diabetes drugs, so as to allow the patient to lead a healthy normal life.

Reducing sugar intake is the best way to decrease high sugar levels,and this can be easily accomplished through a meal to control diabetes. There is no doubt that a diabetic diet is one of the best ways to control sugar elevation. Health complications in this disease, such as kidney problems, can also be easily averted if a prescribed food is followed. A controlled diabetes meal has the capacity to slow down the increase of sugar levels, thus allowing the patient to live without worrying about sugar levels.

Control with Exercise
Exercise for diabetic patients is as important as following a diabetes control food. Daily exercise for about 30 – 60 minutes can go a long way in controlling the disorder. Many people with this issue strictly follow an exercise routine to keep diabetes related health problems at bay. Physical activities such as walking, bicycling, and jogging are some of the most recommended exercises for diabetics.

Erectile Dysfunction Techniques

Avoid High Sugar Foods
Bringing diabetes under control without avoiding high sugar content foods is simply not possible. People suffering from this health condition need to be aware of foods containing high amount of sweet stuff. Eating less sugar is a must for diabetes. Limiting sugar intake is what is expected in the diet to control the disease.

Foods that are high in sugar are:

• Bananas
• Oranges
• Sugarcane
• Concentrated fruit juices
• Canned fruits

Diabetes and Other Disorders

Related Diabetes Reading

Diabetes in Children

Unknown Eating Disorders List

Eating disorders are not limited to just eating too much food or gorging and overeating. It goes way beyond and there are have been many more such syndromes which haven’t got the limelight that they deserve and before it becomes grave issue, it is vital to know them to ensure that you are not facing any of these or if you do then take right step to stop it now.

Night Eating Syndrome: The name explains itself. Person suffering from this disorder will never ever eat in the morning due to the guilt of over eating the previous night. They may wake up in the middle of night feeling awfully hungry and would eat anything that they can lay their hands on. It is said to be the biggest culprit behind obesity which is like a red carpet for all the life style syndromes.

Orthorexia Nervosa: This one is an abnormal obsession with eating healthy and good food. They worry about how the food was made, is it high in nutritious value and how much to eat, etc. When you become a healthy food addict then it becomes an issue of concern. Everyplace that you go would definitely not be as hygienic such apprehensions and obsessions may create problems in your personal life.

Pica: It is about people having craving for some weird food items that one would otherwise think as gross.
Acuphagia – Yearning to eat sharp things
Amylophagia – Yearning for eat washing powder
Cautopyreiophagia – Yearning for eat burnt matches
Coprophagia – Yearning to eat faeces
Geophagia – Yearning to eat soil
Lithophagia – Yearning to eat stones
Mucophagy – Yearning to eat mucus
Pagophagia – Yearning to eat ice
Plumbophagia – Yearning to eat lead
Trichophagia – Yearning to eat hair
Xylophobia – Yearning to eat wood
Hyalophagia- Yearning to eat glass
Saponaceous- Yearning to eat soap

Nocturnal Sleep Eating:
Nocturnal Sleep Eating is to do with people who it in semi conscious state of mind thinking where they are simply not aware about have they eaten in the last meal or have they eaten a meal at all. It is commonly found in people who have high intake of sugar and fats and suffer from severe anxiety and anger pangs.

Effect of High Cholesterol Level on Heart

To understand high blood cholesterol (ko-LES-ter-ol), it is important to know more about it. It is a waxy, fat-like substance that is found in all cells of the body. Your body needs some to work the right way. Your body makes all the cholesterol it needs. It is also found in some of the foods you eat. Your body uses it to make hormones, vitamin D, and substances that help you digest foods. Too much, can be serious. People with high blood cholesterol have a greater chance of getting heart disease.

This disease on its own does not cause symptoms; so many people are unaware that their cholesterol level is too high. It can build up in the walls of your arteries. This build-up is called plaque (plak). Over time, plaque can cause narrowing of the arteries. This is called atherosclerosis (ath-er-o-skler-O-sis), or hardening of the arteries.

Special arteries, called coronary arteries, bring blood to the heart. Narrowing of your coronary arteries due to plaque can stop or slow down the flow of to your heart. When the arteries narrow, the amount of oxygen-rich blood is decreased. This is called coronary heart disease (CHD). Large plaque areas can lead to chest pain called angina (an-JI-nuh or AN-juh-nuh). Angina happens when the heart does not receive enough oxygen-rich blood. Angina is a common symptom of CHD. Some plaques have a thin covering and can burst (rupture), releasing cholesterol and fat into the bloodstream.

The release may cause your blood to clot (and study has also proved that cholesterol drugs can reduce blood clots). A clot can block the blood flow. This blockage can cause angina or a heart attack. Lowering your cholesterol level decreases your chance for having a plaque burst and cause a heart attack. Cholesterol lowering drugs may also slow down, reduce, or even stop plaque from building up.